Are Patients with Inflammatory Bowel Disease on Chronic Immunosuppressive Therapy at Increased Risk of Cervical High-grade Dysplasia/Cancer? A Meta-analysis
Open Access
- 1 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 21 (5) , 1089-1097
Abstract
Background. Immunosuppression is a mainstay of therapy for both induction and maintenance of remission for inflammatory bowel disease (IBD). Women who are chronKeywords
This publication has 32 references indexed in Scilit:
- Inflammatory Bowel Disease and Cervical Neoplasia: A Population-Based Nationwide Cohort StudyClinical Gastroenterology and Hepatology, 2015
- Infections in solid organ transplant HIV-infected patientsClinical Microbiology and Infection, 2014
- Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysisExpert Review of Anti-infective Therapy, 2014
- Women with Inflammatory Bowel Disease Do Not Receive Adequate Cervical Cancer Screening or Pregnancy CounselingInflammatory Bowel Diseases, 2013
- Managing Risks of Neoplasia in Inflammatory Bowel DiseaseCurrent Gastroenterology Reports, 2012
- Cervical dysplasia in immunosuppressed IBD womenInflammatory Bowel Diseases, 2009
- Lack of association between cervical dysplasia and IBD: A large case–control studyInflammatory Bowel Diseases, 2009
- Immunosuppression and Cancer: A Comparison of Risks in Recipients of Organ Transplants and in HIV-Positive IndividualsTransplantation Proceedings, 2006
- Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA PhenotypeClinical Cancer Research, 2005
- Long-term neoplasia risk after azathioprine treatment in inflammatory bowel diseaseThe Lancet, 1994